Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (300313.SZ)
CNY 6.5
(-0.46%)
CNY 6.5
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.74 Million | -7.56 Million | -35.06 Million | 13.68 Million | -34.93 Million | -12.05 Million |
| Net Income | -22.08 Million | -32.04 Million | -30.39 Million | 2.51 Million | -60.05 Million | -1.94 Billion |
| Depreciation & Amortization | 13.82 Million | 13.86 Million | 14.11 Million | 17.35 Million | 23.89 Million | 25.02 Million |
| Deferred income taxes | 422.97 Thousand | 317.77 Thousand | -6.93 Million | 403.28 Thousand | -676.83 Thousand | 444.97 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -24.35 Million | -13.42 Million | -33.72 Million | -14.38 Million | -80.17 Million | 88.85 Million |
| Other non-cash items | 18.86 Million | 24.04 Million | 14.94 Million | 8.19 Million | 81.39 Million | 1.82 Billion |
| Investing Cash Flow | 711.75 Thousand | -659.22 Thousand | 163.56 Million | 14.76 Million | -12.05 Million | 44.43 Million |
| Investments in PPE | -1.64 Million | -1.65 Million | -2.08 Million | -13.56 Million | -13.41 Million | -13.94 Million |
| Acquisitions | 1.63 Million | 274.35 Thousand | 167.15 Million | 10.06 Million | 1.35 Million | 18.89 Million |
| Investment purchases | -1.63 Million | -274.35 Thousand | - | - | - | -53 Million |
| Sales/Maturities of investments | 717.1 Thousand | 717.1 Thousand | - | - | - | 106.43 Million |
| Other Investing Activities | 1.63 Million | 274.35 Thousand | -1.49 Million | 18.25 Million | 0.82 | -13.94 Million |
| Financing Cash Flow | -17.51 Million | -55.38 Million | -31.12 Million | -24.74 Million | -73.59 Million | 72.26 Million |
| Debt repayment | -117.74 Million | -170.56 Million | -199.24 Million | -81.89 Million | -147.72 Million | -226.44 Million |
| Dividends payments | -5.49 Million | -8.79 Million | -10.6 Million | -10.47 Million | -14.02 Million | -21.36 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -925 Thousand | 123.97 Million | 178.72 Million | 67.61 Million | 88.15 Million | 320.07 Million |
| Accounts receivables | -5.28 Million | 7.04 Million | -26.52 Million | 37.62 Million | -36.2 Million | -40.11 Million |
| Accounts payables | 6.36 Million | 5.77 Million | -13.2 Million | -74.95 Million | -41.3 Million | 144.02 Million |
| Inventory | -25.85 Million | -26.55 Million | 12.93 Million | 22.54 Million | -1.99 Million | -15.49 Million |
| Other working capital | 422.97 Thousand | 317.77 Thousand | -6.93 Million | 403.28 Thousand | -676.83 Thousand | 104.35 Million |
| Cash at beginning of period | 47.28 Million | 108.88 Million | 16.3 Million | 12.51 Million | 133.09 Million | 28.49 Million |
| Cash at end of period | 16.73 Million | 47.28 Million | 108.88 Million | 16.3 Million | 12.51 Million | 133.09 Million |
| Capital Expenditure | -1.64 Million | -1.65 Million | -2.08 Million | -13.56 Million | -13.41 Million | -13.94 Million |
| Effect of forex changes on cash | 16.97 | 2.01 Million | -4.79 Million | 88.98 Thousand | 2712.21 | -39.08 Thousand |
| Net cash flow / Change in cash | -30.55 Million | -61.59 Million | 92.58 Million | 3.78 Million | -120.58 Million | 104.6 Million |
| Free Cash Flow | -15.39 Million | -9.21 Million | -37.14 Million | 122.88 Thousand | -48.34 Million | -26 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.79 Million | -20.63 Million | -7.2 Million | -22.08 Million | -8.96 Million | 99.5 Thousand |
| Depreciation & Amortization | - | 3.76 Million | 3.76 Million | 13.82 Million | 3.7 Million | -7.03 Million |
| Deferred income taxes | - | - | - | 422.97 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -1.86 Million | - | -24.35 Million | -31.14 Million | 12.87 Million |
| Other non-cash items | 15.32 Million | 21.22 Million | 14.06 Million | 18.86 Million | 38.57 Million | -10 Million |
| Investing Cash Flow | -1.16 Million | -4347.17 | 1.34 Million | 711.75 Thousand | 1.09 Million | -203.56 Thousand |
| Investments in PPE | -899.16 Thousand | -511.18 Thousand | -10 Thousand | -1.64 Million | -201.73 Thousand | -202.91 Thousand |
| Acquisitions | -199.8 Thousand | 1.55 Million | 20.58 Thousand | 1.63 Million | 1.29 Million | -648.54 |
| Investment purchases | -255 Thousand | - | - | -1.63 Million | - | - |
| Sales/Maturities of investments | 185.64 Thousand | - | 1.43 Million | 717.1 Thousand | - | - |
| Other Investing Activities | - | 100 Thousand | -100 Thousand | 1.63 Million | 0.50 | - |
| Financing Cash Flow | -4.97 Million | -624.95 Thousand | -1.05 Million | -17.51 Million | -2.5 Million | -5.35 Million |
| Debt repayment | -3.4 Million | - | -33 Million | -117.74 Million | -31.96 Million | -94.9 Million |
| Dividends payments | - | -1.3 Million | -1.3 Million | -5.49 Million | -1.29 Million | -1.35 Million |
| Common Stock Repurchased | - | -245 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.57 Million | 676.28 Thousand | 245 Thousand | -925 Thousand | -1.29 Million | 90.9 Million |
| Accounts receivables | - | -5.38 Million | - | -5.28 Million | -5.28 Million | 535.12 Thousand |
| Accounts payables | - | - | - | 6.36 Million | - | -2252.00 |
| Inventory | - | 3.52 Million | - | -25.85 Million | -25.85 Million | 12.33 Million |
| Other working capital | - | - | - | 422.97 Thousand | - | 2252.00 |
| Cash at beginning of period | 18.64 Million | 22.44 Million | 16.73 Million | 47.28 Million | 15.97 Million | 25.58 Million |
| Cash at end of period | 14.04 Million | 18.64 Million | 22.44 Million | 16.73 Million | 16.73 Million | 15.97 Million |
| Capital Expenditure | -899.16 Thousand | -511.18 Thousand | -10 Thousand | -1.64 Million | -201.73 Thousand | -202.91 Thousand |
| Effect of forex changes on cash | - | - | - | 16.97 | 0.65 | -0.11 |
| Net cash flow / Change in cash | -4.6 Million | -3.79 Million | 5.71 Million | -30.55 Million | 763.71 Thousand | -9.61 Million |
| Free Cash Flow | 638.38 Thousand | -3.67 Million | 6.84 Million | -15.39 Million | 1.97 Million | -4.26 Million |
JRVR
002940
000659
0154
BOBR4
FBVI